Evidence map›Paper›PMID 24145416›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Plasmodium falciparum phosphoethanolamine methyltransferase is essential for malaria transmission.

April M Bobenchik, William H Witola, Yoann Augagneur, Laura Nic Lochlainn, Aprajita Garg, Niseema Pachikara, Jae-Yeon Choi, Yang O Zhao, Sahar Usmani-Brown, Albert Lee and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 68 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2026
    Article
  2. Evolutionary Trajectory ofBiomedicines · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The human malaria parasiteProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Adapt or Die: Targeting Unique Transmission-Stage Biology for Malaria Elimination.Frontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Characterization ofFrontiers in cellular and infection microbiology · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Docking predictions basedBMC chemistry · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

April M BobenchikDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520.
William H Witola
Yoann Augagneur
Laura Nic Lochlainn
Aprajita Garg
Niseema Pachikara
Jae-Yeon Choi
Yang O Zhao
Sahar Usmani-Brown
Albert Lee
Sophie H Adjalley
Swapna Samanta
David A Fidock
Dennis R Voelker
Erol Fikrig
Choukri Ben Mamoun
Yale University · USColumbia University · USHoward Hughes Medical Institute · USNational Jewish Health · USUConn Health · USUniversity of Colorado Denver · US

Funding

Pharmacologic Approaches to Combating Resistance to Antimalarial CombinationsR01AI079709 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIDOCK, DAVID A, KYLE, DENNIS E · 2008 to 2011
$2.3M
Columbia University Graduate Training Program in Microbiology and ImmunologyT32AI106711 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Nicholas Arpaia, Uttiya Basu · 2014 to 2026
$2.1M
Nucleoside Transporters of Plasmodium falciparumR01AI051507 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ULLMAN, BUDDY · 2003 to 2007
$1.7M
Howard Hughes Medical InstituteNIAID NIH HHS AI007603NIAID NIH HHS AI51507NIAID NIH HHS R01 AI051507NIAID NIH HHS R01 AI079709NIAID NIH HHS T15 AI007603NIAID NIH HHS T32 AI106711OCPHP CDC HHS PR033005
6 · The paper itself

Abstract

Efficient transmission of Plasmodium species between humans and Anopheles mosquitoes is a major contributor to the global burden of malaria. Gametocytogenesis, the process by which parasites switch from asexual replication within human erythrocytes to produce male and female gametocytes, is a critical step in malaria transmission and Plasmodium genetic diversity. Nothing is known about the pathways that regulate gametocytogenesis and only few of the current drugs that inhibit asexual replication are also capable of inhibiting gametocyte development and blocking malaria transmission. Here we provide genetic and pharmacological evidence indicating that the pathway for synthesis of phosphatidylcholine in Plasmodium falciparum membranes from host serine is essential for parasite gametocytogenesis and malaria transmission. Parasites lacking the phosphoethanolamine N-methyltransferase enzyme, which catalyzes the limiting step in this pathway, are severely altered in gametocyte development, are incapable of producing mature-stage gametocytes, and are not transmitted to mosquitoes. Chemical screening identified 11 inhibitors of phosphoethanolamine N-methyltransferase that block parasite intraerythrocytic asexual replication and gametocyte differentiation in the low micromolar range. Kinetic studies in vitro as well as functional complementation assays and lipid metabolic analyses in vivo on the most promising inhibitor NSC-158011 further demonstrated the specificity of inhibition. These studies set the stage for further optimization of NSC-158011 for development of a class of dual activity antimalarials to block both intraerythrocytic asexual replication and gametocytogenesis.

Indexed as

AntimalarialsEnzyme InhibitorsFemaleFluorescent Antibody TechniqueHumansMalaria, FalciparumMaleMethyltransferasesPlasmodium falciparumRadiometryReproduction, AsexualSerineAntimalarialsEnzyme InhibitorsMethyltransferasesphosphoethanolamine methyltransferaseSerine

Identifiers

PMID24145416
PMCPMC3831454
OpenAlexW2087586442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.